Supriya Lifescience Ltd
NSE:SUPRIYA

Watchlist Manager
Supriya Lifescience Ltd Logo
Supriya Lifescience Ltd
NSE:SUPRIYA
Watchlist
Price: 706.75 INR -0.6%
Market Cap: 56.9B INR
Have any thoughts about
Supriya Lifescience Ltd?
Write Note

Supriya Lifescience Ltd
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Supriya Lifescience Ltd
Other Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Supriya Lifescience Ltd
NSE:SUPRIYA
Other Receivables
₹898.2m
CAGR 3-Years
115%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Other Receivables
₹0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Other Receivables
₹2m
CAGR 3-Years
-21%
CAGR 5-Years
-49%
CAGR 10-Years
-56%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Other Receivables
₹474m
CAGR 3-Years
-35%
CAGR 5-Years
-20%
CAGR 10-Years
-30%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Other Receivables
₹40m
CAGR 3-Years
10%
CAGR 5-Years
0%
CAGR 10-Years
-29%
M
Mankind Pharma Ltd
NSE:MANKIND
Other Receivables
₹859.7m
CAGR 3-Years
-29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Supriya Lifescience Ltd
Glance View

Market Cap
56.9B INR
Industry
Pharmaceuticals

Supriya Lifescience Ltd. supplies active pharmaceuticals ingredients (“APIs”), with a focus on research and development. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2021-12-28. The company focuses on products in various therapeutic segments, such as Anti-Histamine, Anti-Allergics, Vitamins, Anesthetics and Anti-Asthmatics. Its manufacturing facilities include delineated areas for quality check (QC); manufacturing areas with multiple clean rooms; engineering and maintenance; warehouse; materials and finished goods stores; in-house microbiological laboratory, and functional waste treatment plant. The company handles chemical reactions, such as Friedel Craft’s Acylation, Claisen Condensation, Grignard Reaction, Mannich Reaction, Ritter Reaction, Eschweiler Clark reaction, Hydrogenation, Chlorination, Bromination, Decyanation, Isocyanation, Ethoxylation, Nitration, Alkylation, Reduction, Oxidation, Etherification, Chlorosulphonation, Phosphorylation, Chiral resolution, Heterocyclic chemistry, Thermal ring expansion and Protection/Deprotection.

SUPRIYA Intrinsic Value
448.33 INR
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Supriya Lifescience Ltd's Other Receivables?
Other Receivables
898.2m INR

Based on the financial report for Mar 31, 2024, Supriya Lifescience Ltd's Other Receivables amounts to 898.2m INR.

What is Supriya Lifescience Ltd's Other Receivables growth rate?
Other Receivables CAGR 5Y
39%

Over the last year, the Other Receivables growth was 33%. The average annual Other Receivables growth rates for Supriya Lifescience Ltd have been 115% over the past three years , 39% over the past five years .

Back to Top